The above chart presents the market trend analysis for briell pharmaceutical pvt ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 32 transactions, with a transaction quantity of 11585 and a transaction weight of 0.
YearTransactionsQuantityWeight
202550187140
202632115850
Bill of lading data
<
1/15
>
Trade date
2026/03/19
B/L No.
——
Suppliers
infoark industry co.,limited
Buyers
briell pharmaceutical pvt ltd.
POLs
——
PODs
lpaf
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
17564.373992
Hs code
29419090
Product tags
t form,bat,p4,chi,ipm,oar,powder form,azithromycin,pharmaceutical raw material,bran
Product description
PHARMACEUTICAL RAW MATERIAL :AZITHROMYCIN USP43... IN POWDER FORM.........BATCH NO.A20260110.....MFG DT.11.01.2026....EXP.DT.10.01.2030............QTY :125 KGS...BRAND:INFOARK ........ I/O AND SHIPMENT FORM CHINA
Expand
Hs code
29349990
Product tags
t form,bat,abs,vinci,india,ipm,linezolid,powder form,pharmaceutical raw material,bran
Product description
PHARMACEUTICAL RAW MATERIAL :LINEZOLID USP... IN POWDER FORM.........BATCH NO.VLLNZ260001.....MFG DT.01.2026....EXP..DT.12.2029............QTY :100 KGS...BRAND:VINCIT LABS ........ I/O AND SHIPMENT FORM INDIA
Expand
Hs code
29395900
Product tags
t form,bat,doxofylline,india,ipm,kr,powder form,pharmaceutical raw material,bran
Product description
PHARMACEUTICAL RAW MATERIAL :DOXOFYLLINE ... IN POWDER FORM.........BATCH NO.DOX/2602079.....MFG DT.02.2026....EXP..DT.01.2031............QTY :500 KGS...BRAND:KRS ........ I/O AND SHIPMENT FORM INDIA
Expand
Trade date
2026/02/25
B/L No.
——
Suppliers
ss pharma exports
Buyers
briell pharmaceutical pvt ltd.
POLs
——
PODs
lpaf
Supply area
India
Purchas area
Pakistan
Weight
——
Amount
3106.65
Hs code
29329990
Product tags
t form,bat,india,ipm,powder form,pharm,escitalopram oxalate usp,pharmaceutical raw material,bran
Product description
PHARMACEUTICAL RAW MATERIAL:ESCITALOPRAM OXALATE USP IN POWDER FORM.........BATCH NO.EO-012/26.....MFG DT.11.2025....EXP..DT.10.2028............QTY :20KGS...BRAND:SS PHARMA ........ I/O AND SHIPMENT FORM....INDIA
Expand
Product description
PHARMACEUTICAL RAW MATERIAL:DOMPERIDONE BASE IN POWDER FORM.........BATCH NO.LLS/DP/26/012.....MFG DT.01.2026....EXP..DT.12.2030............QTY :100KGS...BRAND:ZEON PHARMA ........ I/O AND SHIPMENT FORM....INDIA
Expand
Hs code
29225000
Product tags
t form,10k,bat,hcl bp,pph,india,dha,ipm,phenylephrine,uk,powder form,pharmaceutical raw material,bran
Product description
PHARMACEUTICAL RAW MATERIAL:PHENYLEPHRINE HCL BP IN POWDER FORM.........BATCH NO.PPH-2511009.....MFG DT.11.2025....EXP..DT.10.2028............QTY :10KGS...BRAND:DHANUKA ........ I/O AND SHIPMENT FORM....INDIA
Expand
briell pharmaceutical pvt ltd. is pakistan Buyer,
and primarily engages in the import and export business of products such as bat,pharmaceutical raw material,drap.
According to the 52wmb.com global trade database, as of 2026-03-19, the company has completed 459 international trades,
with its main trading regions covering india,costa rica,other etc.
The core products include HS29224990,HS29183000,HS29341090 etc,
often transported via lpaf,port lahore air freight unit imports, port lahore etc,
and its main trading partners are morepen laboratories ltd.,snj labs pvt ltd.,progress life sciences pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on briell pharmaceutical pvt ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.